Research Article
A Reappraisal of Women’s Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50–59 Years of Age
Table 2
Women 50–59 years of age at trial entry: WHI Estrogen-Alone Trial outcomes, 13-year cumulative long-term follow-up (intervention phase + postintervention phase).
| ||||||||||||||||||||||||||||||
Coronary heart disease: nonfatal myocardial infarction or coronary death. bGlobal index represents the first event for each participant from among the following: coronary heart disease, stroke, pulmonary embolism, invasive breast cancer, colorectal cancer, hip fracture, or death due to other causes. †95% confidence interval does not include 1.0. ‡Statistically significant (95% CI) for interaction (trend by age). CEE: conjugated equine estrogens; CI: confidence interval; WHI: Women’s Health Initiative. Source for outcomes: [3]. |